Biogen Inc (BIIB)

04:53 AM

Earnings Preview: What To Expect From Biogen's Report - MSN

04:53 AM

07:48 AM

Bleeding Disorders Treatment Market Set to Witness Significant - openPR.com

07:48 AM

07:30 AM

Biogen (NASDAQ:BIIB) shareholders have endured a 61% loss from investing in the stock five years ago - simplywall.st

07:30 AM

06:26 AM

Canada Pension Plan Investment Board Purchases 56,132 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

06:26 AM

04:24 AM

Raymond James Financial Inc. Purchases Shares of 141,968 Biogen Inc. (NASDAQ:BIIB) - MarketBeat

04:24 AM

04:13 AM

PEGylated Proteins Market Positioned for Accelerated Growth - openPR.com

04:13 AM

03:33 AM

Canada Post Corp Registered Pension Plan Acquires Shares of 9,718 Biogen Inc. (NASDAQ:BIIB) - MarketBeat

03:33 AM

Apr 20, 2025

Sterling Capital Management LLC Has $1.32 Million Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 20, 2025

Apr 20, 2025

Leerink Partnrs Has Bearish Estimate for Biogen Q2 Earnings - MarketBeat

Apr 20, 2025

Apr 20, 2025

Biogen/ Eisai win EU approval for Alzheimer’s therapy - MSN

Apr 20, 2025

Apr 20, 2025

Jump Financial LLC Grows Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 20, 2025

Apr 20, 2025

Wedbush Has Positive Forecast for Biogen Q2 Earnings - MarketBeat

Apr 20, 2025

Apr 19, 2025

Wedbush Estimates Biogen's Q1 Earnings (NASDAQ:BIIB) - MarketBeat

Apr 19, 2025

Apr 18, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Sold by Treasurer of the State of North Carolina - MarketBeat

Apr 18, 2025

Apr 18, 2025

Fmr LLC Acquires 376,356 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 18, 2025

Apr 18, 2025

Wells Fargo & Company MN Has $16.98 Million Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 18, 2025

Apr 18, 2025

Cerity Partners LLC Buys 14,306 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 18, 2025

Apr 18, 2025

Global factor VIII deficiency treatment Market Generated - openPR.com

Apr 18, 2025

Apr 18, 2025

Biogen's (BIIB) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat

Apr 18, 2025

Apr 18, 2025

Leerink Partnrs Issues Negative Forecast for Biogen Earnings - MarketBeat

Apr 18, 2025

Apr 18, 2025

Leqembi (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union - TradingView

Apr 18, 2025

Apr 18, 2025

Neuberger Berman Group LLC Cuts Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 18, 2025

Apr 17, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Purchased by LSV Asset Management - MarketBeat

Apr 17, 2025

Apr 17, 2025

Top Development & Construction Projects: Kendall Common – MIT’s Volpe Redevelopment & Biogen’s New Global HQ - Boston Real Estate Times

Apr 17, 2025

Apr 17, 2025

BMO Capital Adjusts Biogen Price Target to $128 From $139 - marketscreener.com

Apr 17, 2025

Apr 17, 2025

Phoenix Financial Ltd. Acquires New Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 17, 2025

Apr 17, 2025

FIL Ltd Sells 91,285 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 17, 2025

Apr 17, 2025

European regulators OK Alzheimer's treatment Leqembi after initial doubts - Chron

Apr 17, 2025

Apr 16, 2025

Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion - Benzinga

Apr 16, 2025

Apr 16, 2025

EU authorizes Eisai-Biogen's drug for early Alzheimer's treatment - Reuters

Apr 16, 2025

Apr 16, 2025

LPL Financial LLC Sells 20,253 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 16, 2025

Apr 16, 2025

Biogen & Partner Eisai Get EU Nod for Alzheimer's Drug Leqembi - Yahoo Finance

Apr 16, 2025

Apr 16, 2025

European regulators OK Alzheimer’s treatment Leqembi after initial doubts - AP News

Apr 16, 2025

Apr 16, 2025

EC authorises Eisai and Biogen’s lecanemab for Alzheimer’s - Yahoo Finance

Apr 16, 2025

Apr 16, 2025

Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday - marketscreener.com

Apr 16, 2025

Apr 16, 2025

Wedbush Cuts Biogen Price Target to $121 From $135, Maintains Neutral Rating - MarketScreener

Apr 16, 2025

Apr 16, 2025

Causeway Capital Management LLC Purchases New Shares in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 16, 2025

Apr 16, 2025

Biogen, Genentech Set for June Trial Over MS Drug Royalties - USA Herald

Apr 16, 2025

Apr 16, 2025

Biogen, Eisai's Alzheimer's Drug Leqembi Approved in EU - MarketScreener

Apr 16, 2025

Apr 16, 2025

Bank of Montreal Can Sells 8,575 Shares of Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 16, 2025

Apr 16, 2025

APG Asset Management US Inc. Buys New Position in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 16, 2025

Apr 16, 2025

Biogen Inc. (NASDAQ:BIIB) Shares Acquired by APG Asset Management N.V. - MarketBeat

Apr 16, 2025

Apr 15, 2025

Leqembi Makes History as First EU-Approved Drug to Target Root Cause of Alzheimer’s Disease - geneonline.com

Apr 15, 2025

Apr 15, 2025

FY2025 EPS Estimates for Biogen Cut by Cantor Fitzgerald - MarketBeat

Apr 15, 2025

Apr 15, 2025

Biogen, Genentech Head To June Trial Over MS Drug Royalties - Law360

Apr 15, 2025

Apr 15, 2025

First Foundation Advisors Raises Stake in Biogen Inc. (NASDAQ:BIIB) - MarketBeat

Apr 15, 2025

Apr 15, 2025

Drug to Treat Underlying Causes of Alzheimer's Gets EU Marketing Approval - marketscreener.com

Apr 15, 2025

Apr 15, 2025

Leqembi®∇ (lecanemab) is the First Medicine that Slows - GlobeNewswire

Apr 15, 2025